Cargando...
FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug Label
The FDA has made it easier for P&T committees to make formulary coverage decisions by expanding the health care economics information that drug manufacturers can provide to them.
Guardado en:
| Publicado en: | P T |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MediMedia USA, Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152691/ https://ncbi.nlm.nih.gov/pubmed/30271100 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|